The purpose of this study was to determine whether human vasoactive intesti
nal peptide (VIP) aggregates in aqueous solution and, if so, whether the pe
ptide interacts with a biomimetic phospholipid monolayer and increases surf
ace pressure. Using a custom-made Teflon trough containing HEPES buffer (pH
7.4) at room temperature and a surface tensiometer, we found that the crit
ical micellar concentration (CMC) of VIP is 0.4 mu M. Surface pressure of a
dipalmitoylphosphatidylcholine (DPPC) monolayer spread over the HEPES buff
er declined significantly over 120 min because of phospholipid decompositio
n. However, injection of VIP at concentrations above CMC into the subphase
of the monolayer elicited a significant concentration-dependent increase in
surface pressure that persisted for 120 min (P < 0.05). Unlike VIP, inject
ion of [(8)Arg]-vasopressin at an equimolar concentration only prevented th
e time-dependent decline in DPPC monolayer surface pressure. Taken together
, these data indicate that human VIP aggregates in aqueous solution and exp
resses surface-active properties at physiological concentrations in vitro.
We suggest that these attributes could have a role in modulating the bioact
ive effects of the peptide in vivo. (C) 2000 Elsevier Science Inc. All righ
ts reserved.